Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations.

Autor: Wierda WG; MD Anderson Cancer Center, Houston, TX, USA. wwierda@mdanderson.org., Rawstron A; Haematological Malignancy Diagnostic Service, Leeds, UK., Cymbalista F; Hôpital Avicenne, AP-HP, UMR Université Paris13/INSERM U978, Bobigny, France., Badoux X; The St. George Hospital, Sydney, NSW, Australia., Rossi D; Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Brown JR; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Egle A; Department of Internal Medicine III with Haematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Cancer Cluster Salzburg, Salzburg, Austria., Abello V; Hospital de San José, Bogota, Colombia., Cervera Ceballos E; Instituto Nacional de Cancerologia/Médica Sur Fundación Clínica, Mexico City, Mexico., Herishanu Y; Tel-Aviv Sourasky Medical Center and Sackler Medical School, Tel Aviv, Israel., Mulligan SP; Royal North Shore Hospital, Sydney, NSW, Australia., Niemann CU; Rigshospitalet, Copenhagen, Denmark., Diong CP; Parkway Cancer Centre, Singapore, Singapore., Soysal T; Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey., Suzuki R; Shimane University Hospital, Shimane, Japan., Tran HTT; Akerhus University Hospital, Lørenskog, Norway., Wu SJ; National Taiwan University Hospital, Taipei, Taiwan., Owen C; Tom Baker Cancer Centre, Calgary, AB, Canada., Stilgenbauer S; Internal Medicine III, Ulm University, Ulm and Internal Medicine 1, Saarland University, Homburg, Germany., Ghia P; Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy., Hillmen P; Leeds Teaching Hospitals, NHS Trust, Leeds, UK.

Publikováno v: Leukemia [Leukemia] 2021 Nov; Vol. 35 (11), pp. 3059-3072. Date of Electronic Publication: 2021 Jun 24.

Corrigendum: CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes.

Autor: Yeap WH, Wong KL, Shimasaki N, Teo EC, Quek JK, Yong HX, Diong CP, Bertoletti A, Linn YC, Wong SC

Publikováno v: Scientific reports [Sci Rep] 2017 Apr 07; Vol. 7, pp. 46202. Date of Electronic Publication: 2017 Apr 07.

Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study.

Autor: Li Z; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; Genome Institute of Singapore, Singapore., Xia Y; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Feng LN; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Chen JR; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Li HM; State Key Laboratory of Molecular Oncology, Beijing, China; Department of Etiology and Carcinogenesis, Beijing Key Laboratory for Carcinogenesis and Cancer Prevention, Beijing, China; Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Cui J; Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Cai QQ; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Sim KS; Genome Institute of Singapore, Singapore., Nairismägi ML; Lymphoma Genomic Translational Research Laboratory, National Cancer Centre Singapore, Singapore., Laurensia Y; Lymphoma Genomic Translational Research Laboratory, National Cancer Centre Singapore, Singapore., Meah WY; Genome Institute of Singapore, Singapore., Liu WS; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Guo YM; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Chen LZ; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Feng QS; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Pang CP; Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China., Chen LJ; Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China., Chew SH; Department of Economics, National University of Singapore, Singapore., Ebstein RP; Department of Psychology, National University of Singapore, Singapore., Foo JN; Genome Institute of Singapore, Singapore., Liu J; Genome Institute of Singapore, Singapore., Ha J; Lymphoma Genomic Translational Research Laboratory, National Cancer Centre Singapore, Singapore., Khoo LP; Lymphoma Genomic Translational Research Laboratory, National Cancer Centre Singapore, Singapore., Chin ST; Lymphoma Genomic Translational Research Laboratory, National Cancer Centre Singapore, Singapore., Zeng YX; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; Beijing Hospital, Beijing, China., Aung T; Singapore Eye Research Institute, Singapore., Chowbay B; Laboratory of Clinical Pharmacology, Division of Medical Sciences, Humphrey Oei Institute of Cancer Research, National Cancer Centre, Singapore; Clinical Pharmacology, SingHealth, Singapore; Office of Clinical Sciences, Duke-National University of Singapore Medical School, Singapore., Diong CP; Department of Haematology, Singapore General Hospital, Singapore., Zhang F; Department of Pathology, Guangdong General Hospital, Guangzhou, China., Liu YH; Department of Pathology, Guangdong General Hospital, Guangzhou, China., Tang T; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Tao M; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Quek R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Mohamad F; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Tan SY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Department of Pathology, Singapore General Hospital, Singapore; Institute of Molecular and Cell Biology, A*STAR, Singapore; Department of Pathology, University of Malaya, Kuala Lumpur, Malaysia; Department of Pathology, National University of Singapore, Singapore., Teh BT; Program in Cancer and Stem Cell Biology, Duke-National University of Singapore Medical School, Singapore; Institute of Molecular and Cell Biology, A*STAR, Singapore; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Ng SB; Department of Pathology, National University of Singapore, Singapore; Cancer Science Institute of Singapore, National University of Singapore, Singapore; Department of Pathology, National University Hospital, National University Health System, Singapore., Chng WJ; Cancer Science Institute of Singapore, National University of Singapore, Singapore; Department of Haematology-Oncology, National University Cancer Institute of Singapore, National University Health System, Singapore., Ong CK; Lymphoma Genomic Translational Research Laboratory, National Cancer Centre Singapore, Singapore., Okada Y; Department of Human Genetics and Disease Diversity, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan; Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; Department of Statistical Genetics, Osaka University Graduate School of Medicine, Osaka, Japan., Raychaudhuri S; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Division of Rheumatology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Partners Center for Personalized Genetic Medicine, Boston, MA, USA; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Institute of Inflammation and Repair, University of Manchester, Manchester, UK; Rheumatology Unit, Department of Medicine, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden., Lim ST; Lymphoma Genomic Translational Research Laboratory, National Cancer Centre Singapore, Singapore; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Office of Education, Duke-National University of Singapore Medical School, Singapore., Tan W; State Key Laboratory of Molecular Oncology, Beijing, China; Department of Etiology and Carcinogenesis, Beijing Key Laboratory for Carcinogenesis and Cancer Prevention, Beijing, China; Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Peng RJ; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Khor CC; Genome Institute of Singapore, Singapore; Singapore Eye Research Institute, Singapore; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Bei JX; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; Genome Institute of Singapore, Singapore; Center for Precision Medicine, Sun Yat-Sen University, Guangzhou, China. Electronic address: beijx@sysucc.org.cn.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2016 Sep; Vol. 17 (9), pp. 1240-7. Date of Electronic Publication: 2016 Jul 25.

Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation.

Autor: Ong SY; Department of Hematology, Singapore General Hospital, Singapore, Singapore., Truong HT; Department of Hematology, Singapore General Hospital, Singapore, Singapore., Diong CP; Department of Hematology, Singapore General Hospital, Singapore, Singapore., Linn YC; Department of Hematology, Singapore General Hospital, Singapore, Singapore., Ho AY; Department of Hematology, Singapore General Hospital, Singapore, Singapore., Goh YT; Department of Hematology, Singapore General Hospital, Singapore, Singapore., Hwang WY; Department of Hematology, Singapore General Hospital, Singapore, Singapore.

Publikováno v: BMC hematology [BMC Hematol] 2015 Jun 19; Vol. 15, pp. 8. Date of Electronic Publication: 2015 Jun 19 (Print Publication: 2015).

Real-world experience with posaconazole prophylaxis in high-risk hematological patients in Singapore: a prospective audit.

Autor: Low CY, Ong WC, Wong E, Ding Y, Diong CP, Jin J, Lim ZY, Hsu LY

Publikováno v: The Journal of infection [J Infect] 2013 Mar; Vol. 66 (3), pp. 291-4. Date of Electronic Publication: 2012 Nov 28.